MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 176 filers reported holding MEDICINES CO in Q2 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $218,000 | -72.0% | 11,400 | -46.2% | 0.01% | -56.2% |
| Q2 2018 | $778,000 | -65.3% | 21,200 | -68.9% | 0.03% | -64.4% |
| Q1 2018 | $2,243,000 | +296.3% | 68,100 | +357.0% | 0.09% | +200.0% |
| Q2 2017 | $566,000 | -79.8% | 14,900 | -79.8% | 0.03% | -71.2% |
| Q3 2015 | $2,805,000 | -5.1% | 73,917 | -28.5% | 0.10% | +5.1% |
| Q2 2015 | $2,956,000 | -1.1% | 103,342 | -3.1% | 0.10% | -3.9% |
| Q1 2015 | $2,989,000 | -16.5% | 106,702 | -33.5% | 0.10% | -37.6% |
| Q3 2014 | $3,578,000 | +169.4% | 160,349 | +250.8% | 0.16% | +139.1% |
| Q2 2014 | $1,328,000 | +84.2% | 45,711 | +80.0% | 0.07% | +81.6% |
| Q1 2014 | $721,000 | -66.3% | 25,399 | -54.2% | 0.04% | -66.7% |
| Q4 2013 | $2,142,000 | – | 55,475 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |